References
- Hartmann C , Smeyers-VerbekeJ, MassartDL, McDowallRD. Validation of bioanalytical chromatographic methods. J. Pharm. Biomed. Anal. 17(2), 193–218 (1998).
- Lee JW , KelleyM, KingLEet al. Bioanalytical approaches to quantify ‘total’ and ‘free’ therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development. AAPS J. 13(1), 99–110 (2011).
- Kaur S , XuK, SaadOM, DereRC, Carrasco-TrigueroM. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics. Bioanalysis5(2), 201–226 (2013).
- Clark T , KingLE. Discovery biotherapeutics bioanalysis; challenges and possible solutions. Bioanalysis4(9), 1003–1007 (2012).
- Boulanger B , DeweW, GilbertA, GovaertsB, Maumy-BertrandM. Risk management for analytical methods based on the total error concept: conciliating the objectives of the pre-study and in-study validation phases. Chemometr. Intell. Lab. Syst. 86, 198–207 (2007).
- Findlay JWA , SmithWC, LeeJWet al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J. Pharm. Biomed. Anal. 21(6), 1249–1273 (2000).
- DeSilva B , SmithW, WeinerRet al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20(11), 1885–1900 (2003).
- Ray CA , DumaualC, WilleyMet al. Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay. J. Pharm. Biomed. Anal. 41(1), 189–195 (2006).
- Neubert H , FountainS, KingLet al. Tissue bioanalysis of biotherapeutics and drug targets to support PK/PD – a perspective. Bioanalysis4(21), 2589–2604 (2012).
- Pandya K , RayCA, BrunnerL, WangJ, LeeJL, DeSilvaB. Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification. J. Pharm. Biomed. Anal. 53, 623–630 (2010).
- Westgard JO , GrothT, AronssonT, FalkH, VerdierCH. Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection. Clin. Chem. 23, 1857–1887 (1977).
- Viswanathan CT , BansalS, BoothBet al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24(10), 1962–1973 (2007).